All news from Anaesthesiology

Researchers Develop a Sensor for the Most Important Human Cancer Gene

TU Dresden-Scientists from the University Cancer Center UCC at the University Hospital Carl Gustav Carus had developed a molecular smoke alert for the TP53 gene, the most important human cancer gene. The alert got switched on when the TP53 gene was mutated in cells. The molecular smoke detector worked like a TP53 sensor that monitored the correct function of the gene. A non-functional TP53 gene activated the sensor and initiated cell death. The study findings were published in the journal Nature Communications.

Scientists identify infection mechanism of rift valley fever virus

A new study published in the journal Science described the mechanism exhibited by the Rift Valley fever virus for the insertion of one of its surface proteins into the host cell membrane, thereby it proliferates and infects the cell. The better understanding of the mechanism would lead to the development of new therapeutic strategies for the infection.

SIDS: Breastfeeding for Two Months Halves the Risk

According to new research, it was found that the risks of Sudden Infant Death Syndrome (SIDS) in infants could be reduced to half if their mother breastfeeds them for at least two months. The researchers showed that mothers do not require breastfeed exclusively for their infants to get the benefit, a potential benefit was identified.

Artificial Heart Muscle Fibers Cultured by Spraying Process

Researchers came one-step ahead to recreate a complex organ in the laboratory that is an artificial heart. An absolute lifesaver for people with cardiac failure is an artificial heart. Prior, one needs to know about how to grow multi-layered, living tissues. The spraying process fulfills the goals to create functioning muscle fibers. An artificial heart that does not trigger any rejection reactions in the body after implantation would be an elegant alternative.

Transplanted Hematopoietic Stem Cells: Damage Caused by Neuro-Muscular Disorder Reversed

The research was led by the Researchers at University of California San Diego School of Medicine. They reported that a single infusion of wild-type hematopoietic stem and progenitor cells (HSPCs) into a mouse model of Friedreich's ataxia (FA) restored the cellular damage caused by the degenerative disease. Transplantation of hematopoietic stem cells led to a potential therapeutic approach for the diseases that are incurable. The study findings are published online in Science Translational Medicine.